• Aixa F Rivera-Pagán, Miguel P Méndez-González, David E Rivera-Aponte, Christian J Malpica-Nieves, Katya V Melnik-Martínez, Astrid Zayas-Santiago, Gerónimo Maldonado-Martínez, Yaroslav M Shuba, Serguei N Skatchkov, and Misty J Eaton.
• Department of Biochemistry, Universidad Central del Caribe, Bayamón, PR, United States.
• Neuroscience. 2018 Aug 1; 384: 54-63.

AbstractA-kinase-anchoring proteins, AKAPs, are scaffolding proteins that associate with kinases and phosphatases, and direct them to a specific submembrane site to coordinate signaling events. AKAP150, a rodent ortholog of human AKAP79, has been extensively studied in neurons, but very little is known about the localization and function of AKAP150 in astrocytes, the major cell type in brain. Thus, in this study, we assessed the localization of AKAP150 in astrocytes and elucidated its role during physiological and ischemic conditions. Herein, we demonstrate that AKAP150 is localized in astrocytes and is up-regulated during ischemia both in vitro and in vivo. Knock-down of AKAP150 by RNAi depolarizes the astrocytic membrane potential and substantially reduces by 80% the ability of astrocytes to take up extracellular potassium during ischemic conditions. Therefore, upregulation of AKAP150 during ischemia preserves potassium conductance and the associated hyperpolarized membrane potential of astrocytes; properties of astrocytes needed to maintain extracellular brain homeostasis. Taken together, these data suggest that AKAP150 may play a pivotal role in the neuroprotective mechanism of astrocytes during pathological conditions.Copyright © 2018 IBRO. Published by Elsevier Ltd. All rights reserved.

18 keywords...

hide…